Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS. Learn why JNJ stock remains a buy despite ...

Chris Della Rocca will oversee J&J's corporate business technology strategy, which includes finance and legal, and report to ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated ...

"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Johnson & Johnson (NYSE:JNJ) with a Outperform ...

J&J wants to appoint lawyer Randi Ellis, who helped it prepare for its third talc-related chapter 11 filing, but the U.S.

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

However, HRSA resisted the plan, threatening to terminate Johnson & Johnson’s PPA and impose significant penalties. This ...

Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced that it is ...